Policlinico Umberto I
Related institution Sapienza University of Rome
ROR: Yes
Works count: 12,910
Citations count: 279,300
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
2012 · Rafael Rosell, Enric Carcereny, et al. · The Lancet Oncology
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
2016 · Giacomo Bellani, John G. Laffey, et al. · JAMA
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
1998 · J P Ridge, Francesca Di Rosa, et al. · Nature